Stephen Machatha - Mar 30, 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Signature
/s/ Stephen Machatha
Stock symbol
ALDX
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
4
Date filed
4/1/2022, 07:37 PM
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Award $0 +64.4K +276.81% $0.00 87.7K Mar 30, 2022 Direct F1, F2
holding ALDX Common Stock 211 Mar 30, 2022 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Employee Stock Option (Right to Buy) Award $0 +250K $0.00 250K Mar 30, 2022 Common Stock 250K $4.52 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
F2 Includes 2,972 shares previously purchased under the Issuer's Employee Stock Purchase Plan.
F3 These shares are held directly by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over these shares for purposes of Section 16 or for any other purposes.
F4 The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.